PALB2 and breast cancer: Moreover, the high penetrance PALB2 P/LPVs are associated with a 33% to 53% lifetime risk of BC [7,8,9], and an international study [8] showed a 5% lifetime risk of OC in carriers of a PALB2 P/LPV.